EA200900137A1 - Комбинация ингибитора if-каналов синусного узла и бета-блокатора - Google Patents

Комбинация ингибитора if-каналов синусного узла и бета-блокатора

Info

Publication number
EA200900137A1
EA200900137A1 EA200900137A EA200900137A EA200900137A1 EA 200900137 A1 EA200900137 A1 EA 200900137A1 EA 200900137 A EA200900137 A EA 200900137A EA 200900137 A EA200900137 A EA 200900137A EA 200900137 A1 EA200900137 A1 EA 200900137A1
Authority
EA
Eurasian Patent Office
Prior art keywords
combination
sinus
hose
channel inhibitor
beta blocker
Prior art date
Application number
EA200900137A
Other languages
English (en)
Inventor
Ги Леребу-Пижоньер
Жан-Анри Кальве
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39666229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200900137(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200900137A1 publication Critical patent/EA200900137A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Комбинация ингибитора If-каналов синусного узла и β-блокатора, а также фармацевтические композиции, которые ее содержат. Лекарственные средства.
EA200900137A 2008-02-14 2009-02-04 Комбинация ингибитора if-каналов синусного узла и бета-блокатора EA200900137A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0800800A FR2927538B1 (fr) 2008-02-14 2008-02-14 Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.

Publications (1)

Publication Number Publication Date
EA200900137A1 true EA200900137A1 (ru) 2009-10-30

Family

ID=39666229

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200900137A EA200900137A1 (ru) 2008-02-14 2009-02-04 Комбинация ингибитора if-каналов синусного узла и бета-блокатора

Country Status (38)

Country Link
US (1) US8217030B2 (ru)
EP (2) EP2409694A1 (ru)
JP (2) JP2009191069A (ru)
KR (1) KR101078133B1 (ru)
CN (1) CN101507726B (ru)
AP (1) AP2010005366A0 (ru)
AR (1) AR070416A1 (ru)
AU (1) AU2009200393B2 (ru)
BR (1) BRPI0900470A2 (ru)
CA (1) CA2654210C (ru)
CO (1) CO6290712A2 (ru)
CR (1) CR11628A (ru)
CU (1) CU24007B1 (ru)
CY (1) CY1114113T1 (ru)
DK (1) DK2090303T3 (ru)
EA (1) EA200900137A1 (ru)
EC (1) ECSP10010402A (ru)
ES (1) ES2421893T3 (ru)
FR (1) FR2927538B1 (ru)
GE (1) GEP20115261B (ru)
HK (1) HK1137341A1 (ru)
HN (1) HN2010001608A (ru)
HR (1) HRP20130617T1 (ru)
IL (1) IL207386A0 (ru)
MA (1) MA31132B1 (ru)
ME (1) ME01014B (ru)
MX (1) MX2009001590A (ru)
MY (1) MY149122A (ru)
NI (1) NI201000139A (ru)
NZ (1) NZ574843A (ru)
PL (1) PL2090303T3 (ru)
PT (1) PT2090303E (ru)
RS (1) RS52834B (ru)
SG (1) SG155130A1 (ru)
SI (1) SI2090303T1 (ru)
UA (1) UA99817C2 (ru)
WO (1) WO2009115669A1 (ru)
ZA (1) ZA200900894B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
US9674435B1 (en) * 2016-07-06 2017-06-06 Lawrence Maxwell Monari Virtual reality platforms for capturing content for virtual reality displays
KR20190001340A (ko) * 2017-06-27 2019-01-04 에리슨제약(주) 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519925A1 (en) * 1989-11-21 1992-12-30 Sepracor, Inc. Use of optically pure s(-) atenolol for the treatment of cardiovascular disorders
FR2681862B1 (fr) 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
JP4194095B2 (ja) * 2001-09-11 2008-12-10 旭化成ファーマ株式会社 脳血管障害、心疾患の予防・治療用医薬組成物
EP1362590B1 (en) 2002-07-25 2004-01-07 Boehringer Ingelheim Pharma GmbH & Co.KG Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
CN101095682A (zh) * 2007-07-23 2008-01-02 北京本草天源药物研究院 一种伊伐布雷定或其药用盐的口服制剂

Also Published As

Publication number Publication date
US20090209515A1 (en) 2009-08-20
JP2012211179A (ja) 2012-11-01
EP2090303B1 (fr) 2013-05-01
CN101507726B (zh) 2012-03-28
HN2010001608A (es) 2013-10-07
JP2009191069A (ja) 2009-08-27
EP2409694A1 (fr) 2012-01-25
CO6290712A2 (es) 2011-06-20
FR2927538A1 (fr) 2009-08-21
AP2010005366A0 (en) 2010-08-31
KR20090088328A (ko) 2009-08-19
MY149122A (en) 2013-07-15
EP2090303A1 (fr) 2009-08-19
ECSP10010402A (es) 2010-09-30
CY1114113T1 (el) 2016-07-27
WO2009115669A1 (fr) 2009-09-24
US8217030B2 (en) 2012-07-10
SI2090303T1 (en) 2013-08-30
CU24007B1 (es) 2014-06-27
CR11628A (es) 2010-11-22
CA2654210C (fr) 2013-06-25
RS52834B (en) 2013-10-31
CN101507726A (zh) 2009-08-19
MA31132B1 (fr) 2010-02-01
NZ574843A (en) 2011-07-29
AU2009200393B2 (en) 2013-11-07
KR101078133B1 (ko) 2011-10-28
NI201000139A (es) 2011-01-10
GEP20115261B (en) 2011-08-10
MX2009001590A (es) 2009-08-24
FR2927538B1 (fr) 2010-02-19
SG155130A1 (en) 2009-09-30
DK2090303T3 (da) 2013-07-29
HK1137341A1 (en) 2010-07-30
HRP20130617T1 (en) 2013-07-31
ES2421893T3 (es) 2013-09-06
AR070416A1 (es) 2010-04-07
UA99817C2 (ru) 2012-10-10
IL207386A0 (en) 2010-12-30
PT2090303E (pt) 2013-05-31
CU20100162A7 (es) 2011-10-31
BRPI0900470A2 (pt) 2009-09-29
AU2009200393A1 (en) 2009-09-03
CA2654210A1 (fr) 2009-08-14
ME01014B (me) 2012-10-20
PL2090303T3 (pl) 2013-07-31
ZA200900894B (en) 2009-12-30

Similar Documents

Publication Publication Date Title
EA201270590A1 (ru) Ингибиторы акт
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp
EA200802008A1 (ru) Фармацевтические композиции
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
CL2011002857A1 (es) Compuestos derivados de fenil o heteroaril piridina, inhibidores de sintasa de aldosterona; composicion farmaceutica que comprende un compuesto; combinacion farmaceutica que comprende un compuesto; y uso de los compuestos en el tratamiento de enfermedades cardiovasculares.
CO6220968A2 (es) Inhibidores heterociclicos de la aspartil proteasa
UA107791C2 (en) Pesticidal compositions
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
EA201100037A1 (ru) Органические соединения
EA201170227A1 (ru) Имидазолкарбоксамиды
EA201170832A1 (ru) Пуриновые соединения
CL2008000418A1 (es) Uso de un antagonista de la il-23 para el tratamiento de una infeccion fungica.
GT200900315A (es) Inhibición de arni de expresión de alfa-enac
UY31688A1 (es) Plaguicidas
PA8667201A1 (es) Nuevos compuestos farmaceuticos
CR20120008A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
EA201401193A1 (ru) Триарильные соединения и композиции, их содержащие
CL2009000914A1 (es) Compuestos derivados de 1-ciano-3-pirrolidinil-n-sustituidas-sulfonamidas, inhibidores de catepsina c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una enfermedad pulmonar obstructiva cronica.
HN2008001723A (es) Nitrilos espirociclicos como inhibidores de proteasa
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
CL2011000165A1 (es) Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento y/o la prevencion del cancer, infecciones, enfermedades inflamatorias y autoinmunes.
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
CL2008001728A1 (es) Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de cancer, infecciones, enfermedades inflamatorias y autoinmunes.
UY31273A1 (es) Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53